Skip to main navigation Skip to search Skip to main content

Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia

  • Riccardo Moia
  • , Mariangela Greco
  • , Paola Boggione
  • , Maura Nicolosi
  • , Riccardo Bruna
  • , Andrea Patriarca
  • , Gianluca Gaidano
  • , Monia Lunghi

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.

Original languageEnglish
Pages (from-to)2293-2294
Number of pages2
JournalClinical Case Reports
Volume8
Issue number11
DOIs
Publication statusPublished - Nov 2020

Keywords

  • ALL
  • CSF xanthochromia
  • hepatotoxicity
  • pegasparaginase

Fingerprint

Dive into the research topics of 'Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Cite this